Study Summary
This trial will test a new way to give the HIV prevention drug PrEP to black men who have sex with men, in order to make it more accessible and reduce HIV incidence.
- HIV/AIDS
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Month 3
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Pharmacy delivered PrEP Intervention
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Pharmacy delivered PrEP Intervention · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
To what extent is this trial engaging the participation of patients?
"Affirmative. Data hosted on clinicaltrials.gov confirms that this medical research, which was first posted on May 19th 2022, is actively searching for individuals to take part in the trial. Approximately 20 participants need to be recruited from 1 centre." - Anonymous Online Contributor
Are there any openings still available for this research project?
"Affirmative, the clinicaltrials.gov website states that this experiment is actively seeking participants. It was initially announced on May 19th 2022 and its most recent alteration occurred on July 19th of the same year. They are recruiting twenty people from a single site." - Anonymous Online Contributor